Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vectura Group plc
DescriptionInhaled apomorphine
Molecular Target Dopamine receptor
Mechanism of ActionDopamine receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat "off" episodes in patients with fluctuating Parkinson's disease (PD); Treat idiopathic Parkinson's disease (PD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today